common.study.topics.clinical

Reaching and Grasping Spinal Cord Injury Using

common.study.values.description

Restoration of Reaching and Grasping Function in Individuals With Spinal Cord Injury Using MyndMove® Neuromodulation Therapy

A two-arm, parallel group, multicentre, single-blind, randomized controlled trial comparing electrical neuromodulation delivered by MyndMoveAR therapy to intensive upper-limb conventional therapy in the treatment of patients with moderate to severe motor impairment to their arms and hands from an incomplete, sub-acute, traumatic spinal cord injury.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Recruiting patients only common.study.methods.is-healthy-yes

Device - MyndMove®

This FES therapy can be used as a short-term therapeutic intervention to help improve voluntary grasping function

Conventional Therapy

Conventional training involves repetitive practice of upper extremity movements with manual assistance provided by a therapist as needed.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Restoration of Reaching and Grasping Function in Individuals With Spinal Cord Injury Using MyndMove® Neuromodulation Therapy

common.study.values.clinical-trial-id

NCT03439319

participant.views.study.view.id

0dNzNd